OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Salmon-Céron, D; Durier, C; Desaint, C; Cuzin; Surenaud, M; Hénin, Y; Lelièvre, J; Bonnet, B; Pialoux, G; Poizot-Martin, I; Ben Hamouda, N; Jackson, A; Flys, C; Guérin, C; Aboulker, J; Choppin, J; Launay, O

doi:10.1186/1742-4690-6-S3-O25

Retrovirology

Article metrics
Last updated: Tue, 20 May 2025 21:48:33 Z

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Access & Citations

2096

Article Accesses
Data not available

Web of Science
Data not available

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1742-4690

Contact us

Submission enquiries: journalsubmissions@springernature.com